Galderma Group AG
SIX:GALD
Cash Flow Statement
Cash Flow Statement
Galderma Group AG
| Dec-2024 | Jun-2025 | ||
|---|---|---|---|
| Operating Cash Flow | |||
| Net Income |
231
|
378
|
|
| Depreciation & Amortization |
293
|
309
|
|
| Other Non-Cash Items |
477
|
390
|
|
| Cash Taxes Paid |
90
|
105
|
|
| Cash Interest Paid |
286
|
178
|
|
| Change in Working Capital |
(513)
|
(126)
|
|
| Cash from Operating Activities |
488
N/A
|
951
+95%
|
|
| Investing Cash Flow | |||
| Capital Expenditures |
(275)
|
(218)
|
|
| Other Items |
(51)
|
(1)
|
|
| Cash from Investing Activities |
(326)
N/A
|
(219)
+33%
|
|
| Financing Cash Flow | |||
| Net Issuance of Common Stock |
2 151
|
(338)
|
|
| Net Issuance of Debt |
(2 176)
|
(291)
|
|
| Cash Paid for Dividends |
0
|
(41)
|
|
| Other |
(33)
|
(6)
|
|
| Cash from Financing Activities |
(58)
N/A
|
(676)
-1 066%
|
|
| Change in Cash | |||
| Effect of Foreign Exchange Rates |
(14)
|
18
|
|
| Net Change in Cash |
90
N/A
|
74
-18%
|
|
| Free Cash Flow | |||
| Free Cash Flow |
213
N/A
|
733
+244%
|
|